Search research articles
Contact Us
Filters
Showing results (191-200 of 194) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 194 results.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
May 19, 2021
Structural and Functional Imaging of the Retina in Central Retinal Artery Occlusion - Current Approaches and Future Directions
Brian Mac Grory, Matthew Schrag, Sven Poli, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2013
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1
Christopher A Hurley, Wade S Blair, Richard J Bull, et al.
Journal of Medicinal Chemistry
|
May 18, 2012
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors
Janusz J Kulagowski, Wade Blair, Richard J Bull, et al.
Journal of Medicinal Chemistry
|
June 16, 2012
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2
Mark Zak, Rohan Mendonca, Mercedesz Balazs, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 194) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 194 results.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
May 19, 2021
Structural and Functional Imaging of the Retina in Central Retinal Artery Occlusion - Current Approaches and Future Directions
Brian Mac Grory, Matthew Schrag, Sven Poli, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2013
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1
Christopher A Hurley, Wade S Blair, Richard J Bull, et al.
Journal of Medicinal Chemistry
|
May 18, 2012
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors
Janusz J Kulagowski, Wade Blair, Richard J Bull, et al.
Journal of Medicinal Chemistry
|
June 16, 2012
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2
Mark Zak, Rohan Mendonca, Mercedesz Balazs, et al.
Page
of 20